Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine In Depression - Intensive Care Unit Trial (KID-ICU): A Phase II Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Ketamine Infusion for Depressive Symptoms in Intensive Care Unit Patients

NCT07639359 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.

NCT NCT07639359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07639359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine In Depression - Intensive Care Unit Trial (KID-ICU): A Phase II Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Ketamine Infusion for Depressive Symptoms in Intensive Care Unit Patients
Lead sponsor
Hospital Italiano de Buenos Aires
Phase
Phase 2
Overall status
Recruiting
Start date
May 14, 2026
Completion date
June 1, 2028
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, depressive symptoms